Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
89.23 EUR | -0.70% | -0.87% | -0.60% |
May. 27 | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
May. 27 | Sanofi: FDA grants priority review in myeloma | CF |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Other languages